{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T08:43:12Z","timestamp":1789288992995,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05582-2","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T08:14:19Z","timestamp":1779783259000},"page":"3017-3030","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["NEFL\u207aNEFM\u207a myeloid-reprogrammed cells promote ccRCC progression through CX3CL1-CX3CR1-mediated Tregs chemotaxis"],"prefix":"10.1007","volume":"481","author":[{"given":"Shuran","family":"Zi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenduo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengrunhong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyang","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"key":"5582_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.9","volume":"3","author":"JJ Hsieh","year":"2017","unstructured":"Hsieh JJ, Purdue MP, Signoretti S et al (2017) Renal cell carcinoma. Nat Rev Dis Primers 3:17009","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"5582_CR2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nrurol.2011.64","volume":"8","author":"VA Valera","year":"2011","unstructured":"Valera VA, Merino MJ (2011) Misdiagnosis of clear cell renal cell carcinoma. Nat Rev Urol 8(6):321\u201333","journal-title":"Nat Rev Urol"},{"issue":"4","key":"5582_CR3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41571-020-00455-z","volume":"18","author":"DA Braun","year":"2021","unstructured":"Braun DA, Bakouny Z, Hirsch L et al (2021) Beyond conventional immune-checkpoint inhibition - novel immunotherapies for renal cell carcinoma. Nat Rev Clin Oncol 18(4):199\u2013214","journal-title":"Nat Rev Clin Oncol"},{"key":"5582_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26125577","author":"J Rysz","year":"2025","unstructured":"Rysz J, Lawinski J, Franczyk B et al (2025) Immune checkpoint inhibitors in clear cell renal cell carcinoma (ccRCC). Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26125577","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5582_CR5","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s00262-024-03938-5","volume":"74","author":"Q WANG","year":"2025","unstructured":"Wang Q, Chen J, Wang Y et al (2025) The profiles of immunosuppressive microenvironment in the Lauren intestinal-type gastric adenocarcinoma. Cancer Immunol Immunother 74(3):82","journal-title":"Cancer Immunol Immunother"},{"issue":"3","key":"5582_CR6","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41423-020-00613-4","volume":"18","author":"A Mantovani","year":"2021","unstructured":"Mantovani A, Marchesi F, Jaillon S et al (2021) Tumor-associated myeloid cells: diversity and therapeutic targeting. Cell Mol Immunol 18(3):566\u201378","journal-title":"Cell Mol Immunol"},{"issue":"4","key":"5582_CR7","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/febs.14288","volume":"285","author":"C Porta","year":"2018","unstructured":"Porta C, Sica A, Riboldi E (2018) Tumor-associated myeloid cells: new understandings on their metabolic regulation and their influence in cancer immunotherapy. FEBS J 285(4):717\u201333","journal-title":"FEBS J"},{"issue":"1","key":"5582_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-023-01473-x","volume":"16","author":"X Cheng","year":"2023","unstructured":"Cheng X, Wang H, Wang Z et al (2023) Tumor-associated myeloid cells in cancer immunotherapy. J Hematol Oncol 16(1):71","journal-title":"J Hematol Oncol"},{"issue":"1","key":"5582_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40364-023-00549-7","volume":"12","author":"Y QIAN","year":"2024","unstructured":"QIAN Y, YIN Y, ZHENG X et al (2024) Metabolic regulation of tumor-associated macrophage heterogeneity: insights into the tumor microenvironment and immunotherapeutic opportunities [J]. Biomark Res 12(1):1","journal-title":"Biomark Res"},{"key":"5582_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26115352","author":"Y Iwahashi","year":"2025","unstructured":"Iwahashi Y, Ishida Y, Mukaida N et al (2025) Pathophysiological roles of the CX3CL1-CX3CR1 axis in renal disease, cardiovascular disease, and cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26115352","journal-title":"Int J Mol Sci"},{"issue":"1\u20132","key":"5582_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jneuroim.2010.05.007","volume":"224","author":"F Marchesi","year":"2010","unstructured":"Marchesi F, Locatelli M, Solinas G et al (2010) Role of CX3CR1\/CX3CL1 axis in primary and secondary involvement of the nervous system by cancer. J Neuroimmunol 224(1\u20132):39\u201344","journal-title":"J Neuroimmunol"},{"issue":"12","key":"5582_CR12","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1002\/ijc.34921","volume":"154","author":"H Wang","year":"2024","unstructured":"Wang H, Liu S, Zhan J et al (2024) Shaping the immune-suppressive microenvironment on tumor-associated myeloid cells through tumor-derived exosomes. Int J Cancer 154(12):2031\u201342","journal-title":"Int J Cancer"},{"key":"5582_CR13","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191869","author":"A Etzerodt","year":"2020","unstructured":"Etzerodt A, Moulin M, Doktor TK et al (2020) Tissue-resident macrophages in omentum promote metastatic spread of ovarian cancer. J Exp Med. https:\/\/doi.org\/10.1084\/jem.20191869","journal-title":"J Exp Med"},{"issue":"5","key":"5582_CR14","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.immuni.2019.03.009","volume":"50","author":"R Zilionis","year":"2019","unstructured":"Zilionis R, Engblom C, Pfirschke C et al (2019) Single-cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species. Immunity 50(5):1317\u201334 e10","journal-title":"Immunity"},{"issue":"5","key":"5582_CR15","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cell.2018.05.060","volume":"174","author":"E Azizi","year":"2018","unstructured":"Azizi E, Carr AJ, Plitas G et al (2018) Single-cell map of diverse immune phenotypes in the breast tumor microenvironment. Cell 174(5):1293\u2013308 e36","journal-title":"Cell"},{"issue":"4","key":"5582_CR16","first-page":"736","volume":"169","author":"S CHEVRIER","year":"2017","unstructured":"Chevrier S, Levine J H, Zanotelli V R T et al (2017) Immune Atlas Clear Cell Ren Cell Carcinoma [J] Cell 169(4):736\u2013749 e18","journal-title":"Immune Atlas Clear Cell Ren Cell Carcinoma [J] Cell"},{"issue":"3","key":"5582_CR17","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","volume":"184","author":"S Cheng","year":"2021","unstructured":"Cheng S, Li Z, Gao R et al (2021) A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell 184(3):792-809 e23","journal-title":"Cell"},{"issue":"1","key":"5582_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50478-8","volume":"15","author":"W Li","year":"2024","unstructured":"Li W, Pan L, Hong W et al (2024) A single-cell pan-cancer analysis to show the variability of tumor-infiltrating myeloid cells in immune checkpoint blockade. Nat Commun 15(1):6142","journal-title":"Nat Commun"},{"issue":"40","key":"5582_CR19","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abn5535","volume":"8","author":"PC Tang","year":"2022","unstructured":"Tang PC, Chung JY, Liao J et al (2022) Single-cell RNA sequencing uncovers a neuron-like macrophage subset associated with cancer pain. Sci Adv 8(40):eabn5535","journal-title":"Sci Adv"},{"issue":"10","key":"5582_CR20","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1016\/j.ymthe.2022.01.046","volume":"30","author":"Z Xu","year":"2022","unstructured":"Xu Z, Chen Y (2022) Role of exosomal non-coding RNAs from tumor cells and tumor-associated macrophages in the tumor microenvironment. Mol Ther 30(10):3133\u20133154","journal-title":"Mol Ther"},{"issue":"7","key":"5582_CR21","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1093\/brain\/awaa098","volume":"143","author":"AR Gafson","year":"2020","unstructured":"Gafson AR, Barthelemy NR, Bomont P et al (2020) Neurofilaments: neurobiological foundations for biomarker applications. Brain 143(7):1975\u201398","journal-title":"Brain"},{"issue":"5","key":"5582_CR22","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1083\/jcb.140.5.1167","volume":"140","author":"J Kong","year":"1998","unstructured":"Kong J, Tung VW, Aghajanian J et al (1998) Antagonistic roles of neurofilament subunits NF-H and NF-M against NF-L in shaping dendritic arborization in spinal motor neurons. J Cell Biol 140(5):1167\u201376","journal-title":"J Cell Biol"},{"issue":"3","key":"5582_CR23","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.bbrc.2007.09.137","volume":"364","author":"Y Saitoh","year":"2007","unstructured":"Saitoh Y, Koizumi K, Sakurai H et al (2007) RANKL-induced down-regulation of CX3CR1 via PI3K\/Akt signaling pathway suppresses Fractalkine\/CX3CL1-induced cellular responses in RAW264.7 cells [J]. Biochem Biophys Res Commun 364(3):417\u2013422","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"5582_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1515\/sjpain-2019-0138","volume":"20","author":"M Malcangio","year":"2019","unstructured":"Malcangio M (2019) Role of the immune system in neuropathic pain. Scand J Pain 20(1):33\u20137","journal-title":"Scand J Pain"},{"key":"5582_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/cells9102277","author":"P Pawelec","year":"2020","unstructured":"Pawelec P, Ziemka-Nalecz M, Sypecka J et al (2020) The impact of the CX3CL1\/CX3CR1 axis in neurological disorders. Cells. https:\/\/doi.org\/10.3390\/cells9102277","journal-title":"Cells"},{"issue":"1","key":"5582_CR26","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2024.2320951","volume":"13","author":"J Su","year":"2024","unstructured":"Su J, Mao X, Wang L et al (2024) Lactate\/GPR81 recruits regulatory T cells by modulating CX3CL1 to promote immune resistance in a highly glycolytic gastric cancer. Oncoimmunology 13(1):2320951","journal-title":"Oncoimmunology"},{"key":"5582_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252413682","author":"H Yang","year":"2024","unstructured":"Yang H, Yang J, Park N et al (2024) Adoptive transfer of CX3CR1-transduced Tregs homing to the forebrain in lipopolysaccharide-induced neuroinflammation and 3xTg Alzheimer\u2019s disease models. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms252413682","journal-title":"Int J Mol Sci"},{"issue":"4","key":"5582_CR28","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.ccr.2011.02.006","volume":"19","author":"J Chen","year":"2011","unstructured":"Chen J, Yao Y, Gong C et al (2011) CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3. Cancer Cell 19(4):541\u201355","journal-title":"Cancer Cell"},{"issue":"2","key":"5582_CR29","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.3892\/or.2015.4470","volume":"35","author":"J Tang","year":"2016","unstructured":"Tang J, Xiao L, Cui R (2016) CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE\/TGF-alpha\/EGFR pathway in hypoxic androgen-independent prostate cancer cells. Oncol Rep 35(2):1153\u201362","journal-title":"Oncol Rep"},{"issue":"2","key":"5582_CR30","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.urolonc.2012.12.006","volume":"32","author":"X Yao","year":"2014","unstructured":"Yao X, Qi L, Chen X et al (2014) Expression of CX3CR1 associates with cellular migration, metastasis, and prognosis in human clear cell renal cell carcinoma. Urol Oncol 32(2):162\u201370","journal-title":"Urol Oncol"},{"issue":"1","key":"5582_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010183","volume":"13","author":"X Song","year":"2025","unstructured":"Song X, Zhu Y, Geng W et al (2025) Spatial and single-cell transcriptomics reveal cellular heterogeneity and a novel cancer-promoting Treg cell subset in human clear-cell renal cell carcinoma. J Immunother Cancer 13(1):e010183","journal-title":"J Immunother Cancer"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05582-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05582-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05582-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T08:23:54Z","timestamp":1784276634000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05582-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":31,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["5582"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05582-2","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}